BioCentury
ARTICLE | Company News

Samsung planned $22B investment includes biopharma, AI

August 10, 2018 6:34 AM UTC

Samsung Group (Seoul, South Korea) said it would invest W25 trillion ($22.2 billion) over the next three years in biopharmaceuticals and artificial intelligence, among other sectors.

While Samsung did not disclose details of the plans, it did say it will continue to invest in its contract manufacturing and biosimilar businesses, which includes support of biosimilar development and manufacturing...

BCIQ Company Profiles

Samsung Group